The European health agency says decisions on doxycycline post-exposure prophylaxis use should be made at the individual level, following clinical judgement and national guidelines.
Reduced funding will erode decades of progress and impede future advancements, but there is hope for the future with alternative resources.
Debio1453 is a first-in-class antibiotic candidate that targets an enzyme that’s essential for the growth of Neisseria gonorrhoeae.
Data on more than 1.4 millions incarcerated individuals in 43 countries shows STI rates are particularly high in adolescents and women.
Syphilis rates have been rising in pregnant women and babies for about a decade.
The report is in response to a continent-wide surge in STIs since 2014.
Zoliflodacin and gepotidacin are the first new antibiotics approved for treating gonorrhea in decades.
Study findings show that a single oral dose of zoliflodacin is noninferior to the standard treatment regimen for uncomplicated gonorrhea.
Officials warn rising drug resistance could undo decades of progress in controlling HIV, hepatitis, and sexually transmitted infections.
Data from a new surveillance report show rising resistance to ceftriaxone and cefixime, the two antibiotics currently recommended for gonorrhea treatment.
